The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cancers, Pain Clinical Trial

Official title:
A Pilot Study: The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients

Status Completed

Clinical Trial Summary

The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.

n/a

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

NCT number	NCT01043068
Study type	Interventional
Source	National Cancer Center, Korea
Contact
Status	Completed
Phase	Phase 4
Start date	January 2010
Completion date	December 2010

See also
Status	Clinical Trial	Phase
Completed	`NCT00904280` - Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy	Phase 3
Completed	`NCT00589823` - Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids	Phase 3
Completed	`NCT00458510` - Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain	Phase 3
Completed	`NCT00012896` - Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines	N/A